DrugDashboards

Market view

dextromethorphan hbr guaifenesin · Liquid

1 marketed package NDCs · 1 active manufacturer

Most dispensed: DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 200 mg/20mL · Solution · #1 bottle, plastic/carton / 118 ml in 1 bottle, plastic · DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 200 mg/20mL · Solution · #1 bottle, plastic/carton / 237 ml in 1 bottle, plastic

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for dextromethorphan hbr guaifenesin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Tussin DMAug 19, 2026
    Price down
    NADAC $0.01485 → $0.01453 per unit (-2.15%)
  • Tussin DMAug 19, 2026
    Price up
    NADAC $0.01997 → $0.02054 per unit (+2.85%)
  • Tussin DMJul 22, 2026
    Price down
    NADAC $0.01525 → $0.01485 per unit (-2.62%)
  • Tussin DMJul 22, 2026
    Price down
    NADAC $0.02027 → $0.01997 per unit (-1.48%)

Same drug class

Other molecules FDA puts in Uncompetitive N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Dextromethorphan hbr guaifenesin in shortage right now?
No. FDA does not currently list Dextromethorphan hbr guaifenesin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Dextromethorphan hbr guaifenesin?
2 companies have marketed Dextromethorphan hbr guaifenesin in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Dextromethorphan hbr guaifenesin cost?
The typical pharmacy pays about $0.0175 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.